United Kingdom Soft Gelatin Capsules Market Research Report: Size, Share, Trends & Forecast (2026-2032)

United Kingdom Soft Gelatin Capsules Market Report Key Takeaways:

• The United Kingdom Soft Gelatin Capsules Market size was valued at around USD 275 million in 2025 and is projected to grow from USD 290.95 million in 2026 to USD 408.07 million by 2032, exhibiting a CAGR of 5.8% during 2026-32.
• By Type, the Gelatin Soft Capsules segment represented a significant share of about 78% in the United Kingdom Soft Gelatin Capsules Market in 2026.
• By Application, the Nutraceutical segment seized a significant share of about 51% in the United Kingdom Soft Gelatin Capsules Market in 2026.
• Leading soft gelatin capsule companies in the U.K. market are EuroCaps Ltd., Catalent Inc., Aenova Group, Lonza Group Ltd., Soft Gel Technologies Inc., Captek Softgel International, INW Bee Health Ltd., Supplement Factory Ltd., HTC Health Ltd., Nutra Direct Ltd., NextPharma, Strides Pharma Science Ltd., Cloverty Ltd., and others.

Market Insights & Analysis: United Kingdom Soft Gelatin Capsules Market (2026-32):

The United Kingdom Soft Gelatin Capsules Market size was valued at around USD 275 million in 2025 and is projected grow from USD 290.95 million in 2026 to USD 408.07 million by 2032, exhibiting a CAGR of 5.8% during the forecast period, i.e., 2026-32.

The United Kingdom soft gelatin capsules market has experienced stable historical growth, supported by sustained expansion in healthcare spending and pharmaceutical consumption. UK NHS expenditure reached approximately USD 300 billion in 2024/25, with long-term annual growth of around 3.6%, reflecting consistent demand for medicines and drug delivery systems . This expanding expenditure base has reinforced the adoption of efficient dosage forms such as soft gelatin capsules. Over time, increasing use in both prescription therapies and over-the-counter supplements has strengthened market penetration.

Current market conditions are shaped by diversified end-user demand across pharmaceutical companies, nutraceutical manufacturers, and healthcare institutions. Retail and online pharmacies continue to expand accessibility, while hospitals maintain stable demand for capsule-based medications in chronic disease management. The UK’s Medicines and Healthcare Products Regulatory Agency enforces stringent safety, quality, and efficacy standards, ensuring high product reliability and strengthening trust in capsule-based formulations . This robust regulatory framework supports consistent product adoption across institutional and commercial channels.

Government-led initiatives and industry investments further reinforce market expansion by promoting innovation and domestic pharmaceutical capabilities. The UK government’s focus on supply chain resilience has encouraged investment in local manufacturing infrastructure and medicine production reliability. In parallel, companies such as GSK have committed approximately USD 30 billion toward R&D and manufacturing capacity, while AstraZeneca continues to leverage its UK-based innovation hub alongside global expansion . These developments collectively strengthen production capabilities and support advanced drug delivery technologies.

Looking ahead, the market is expected to maintain stable growth driven by demographic aging, rising prevalence of chronic diseases, and increasing consumer focus on preventive healthcare. Industry participants are investing in plant-based softgel technologies, improved bioavailability formulations, and sustainable manufacturing practices. Continued expansion of nutraceutical consumption and institutional healthcare demand will further support market stability. These combined economic, regulatory, and industry-driven factors are expected to sustain long-term demand for soft gelatin capsules in the United Kingdom.

United Kingdom Soft Gelatin Capsules Market Recent Developments:

• 2024: Roquette launched its LYCAGEL® Flex softgel excipient system, enabling manufacturers to develop customizable plant-based softgel capsules with enhanced stability, performance, and formulation flexibility. The innovation supports the growing shift toward vegan softgels in nutraceutical and pharmaceutical applications.

United Kingdom Soft Gelatin Capsules Market Scope:

United Kingdom Soft Gelatin Capsules Market Driver:

Aging Population and Chronic Disease Burden

The aging population in the United Kingdom has emerged as a fundamental structural driver of healthcare demand, intensifying steadily in recent years. According to the Office for National Statistics, individuals aged 65 and above accounted for approximately 19.5% of the population in 2024, reflecting a rapidly expanding elderly demographic . This shift is directly associated with a higher prevalence of chronic conditions such as cardiovascular diseases, diabetes, and arthritis. As life expectancy increases, long-term medication and supplement consumption have become more widespread, structurally expanding demand for oral dosage forms.

This demographic trend is measurably increasing demand across pharmaceutical and nutraceutical end-user segments. NHS data indicate that older adults account for a significant proportion of prescriptions due to multi-morbidity and continuous treatment requirements. Soft gelatin capsules are particularly suited to this population due to ease of swallowing and enhanced bioavailability. Supporting this context, a 2025 clinical study found that vitamin D supplementation among adults aged 50 and above could slow biological aging by nearly three years, reinforcing sustained supplement consumption among elderly populations .

The impact of this driver extends beyond short-term adoption and contributes directly to long-term market volume expansion. Government health strategies increasingly emphasize preventive care and chronic disease management, as reflected in the UK’s 2025 NHS 10-Year Health Plan , which prioritizes a systemic shift toward early intervention and long-term health management. This policy direction ensures continuous demand for medicines and supplements. As a result, the expanding elderly population increases both the number of consumers and the duration of treatment, structurally driving sustained demand for soft gelatin capsules.

United Kingdom Soft Gelatin Capsules Market Trend:

Shift Toward Vegetarian & Plant-Based Softgel Capsules

The shift toward vegetarian and plant-based softgel capsules has accelerated in the United Kingdom due to evolving consumer preferences and dietary transitions. Increasing adoption of vegan and flexitarian lifestyles has driven demand for non-animal-derived healthcare and supplement products. UK healthcare guidance also recommends supplementation, such as vitamin B12, for individuals following plant-based diets, reinforcing structurally higher reliance on compatible delivery formats. This convergence of dietary behavior and medical guidance has expanded demand for plant-based softgel alternatives.

This trend is driving structural changes across the value chain, particularly in raw material sourcing and manufacturing technologies. Manufacturers are transitioning from animal-derived gelatin to plant-based polymers such as starch and gellan gum, requiring new formulation expertise and processing capabilities. Industry participants are actively investing in this transition, as demonstrated by Sirio Europe’s 2025 launch of its Plantegrity® platform, a patented plant-based softgel technology designed to replace conventional gelatin shells . Such innovations are reshaping product development pipelines and contract manufacturing strategies.

The persistence of this trend is supported by sustainability priorities, regulatory focus on transparent labeling, and long-term consumer preference shifts. Plant-based products are increasingly positioned as environmentally sustainable and ethically sourced alternatives, aligning with broader UK policy and consumer expectations. As companies continue to invest in scalable plant-based technologies and expand product portfolios, vegetarian softgels are expected to play a central role in future market evolution, influencing both formulation strategies and competitive positioning.

United Kingdom Soft Gelatin Capsules Market Opportunity:

Increasing Demand for Preventive Healthcare

The increasing emphasis on preventive healthcare in the United Kingdom has created a structurally favorable opportunity for new entrants in the soft gelatin capsules market. The UK government’s 2025 NHS 10-Year Health Plan prioritizes a systemic shift from treatment to prevention through early intervention and long-term health management. This policy direction is reshaping healthcare consumption patterns toward self-care and wellness. As a result, demand for dietary supplements and preventive formulations is expanding across multiple population segments.

This shift translates directly into tangible market demand, supported by the rising incidence of nutritional deficiencies and chronic health risks. NHS data reported over 191,000 hospital admissions linked to iron deficiency in 2023–24, alongside broader increases in vitamin-related conditions . Such trends are driving consistent consumption of supplements, including vitamin D, B12, and omega-3, commonly delivered via softgel formats. The expansion of retail and online pharmacy channels further enables frequent and accessible product purchases, reinforcing repeat consumption behavior.

This opportunity is particularly advantageous for new and emerging players due to relatively lower entry barriers in nutraceutical manufacturing and distribution. Smaller companies can rapidly introduce targeted, preventive formulations aligned with evolving consumer health priorities. Additionally, digital-first distribution models and contract manufacturing enable cost-efficient scaling without large capital investment. As preventive healthcare continues to gain policy and consumer support, new entrants can leverage innovation and niche positioning to capture sustained demand growth.

United Kingdom Soft Gelatin Capsules Market Challenge:

Competition from Alternative Dosage Forms

Competition from alternative dosage forms such as tablets, hard capsules, and gummies represents a key structural challenge in the United Kingdom soft gelatin capsules market. This challenge has intensified due to shifting consumer preferences toward convenience, affordability, and product variety. The widespread availability of multiple supplement formats across pharmacies and retail channels has reduced reliance on softgel capsules. As a result, consumers increasingly choose formats based on ease of use and price sensitivity.

This competitive pressure is measurably impacting demand patterns across nutraceutical and pharmaceutical segments. Tablets and hard capsules offer lower manufacturing costs and greater formulation flexibility, enabling competitive pricing strategies. Additionally, gummies are gaining popularity due to improved taste and higher consumer acceptance, particularly among younger demographics. The growing presence of these formats across retail shelves is directly diverting demand away from softgel capsules.

This challenge restricts market expansion by limiting adoption and increasing competitive pressure on manufacturers. Companies must invest in differentiation and advanced formulations to remain competitive, raising operational complexity. Smaller players face scalability challenges due to higher production requirements for softgels. Consequently, competition from alternative dosage forms continues to constrain growth and market penetration.

United Kingdom Soft Gelatin Capsules Market (2026-32) Segmentation Analysis:

The United Kingdom Soft Gelatin Capsules market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2026–32 at the country level. Based on the analysis, the market has been further classified as;

Based on Type:

• Gelatin Soft Capsules
• Non-Gelatin (Vegetarian) Soft Capsules

Gelatin Soft Capsules dominate the United Kingdom Soft Gelatin Capsules Market, accounting for approximately 78% of total demand, primarily due to their established manufacturing efficiency, cost-effectiveness, and widespread pharmaceutical acceptance. Traditional gelatin-based formulations remain the preferred choice for high-volume applications, particularly in pharmaceutical and nutraceutical products requiring stable encapsulation of lipid-soluble ingredients. According to the UK Medicines and Healthcare products Regulatory Agency (MHRA), stringent quality and efficacy standards favor well-established excipients with proven safety profiles, reinforcing the continued use of gelatin in capsule production.

Industrial capacity and supply chain maturity further strengthen this dominance. The United Kingdom benefits from a well-developed pharmaceutical manufacturing ecosystem supported by large-scale production infrastructure and contract manufacturing organizations. Gelatin capsules are easier to produce at scale compared to plant-based alternatives, requiring less complex formulation processes and offering higher production efficiency. This enables manufacturers to maintain consistent output and competitive pricing, which is critical for high-volume supplement categories such as omega-3 and vitamin-based products.

Additionally, gelatin soft capsules benefit from decades of clinical validation and regulatory familiarity, reducing formulation risks and accelerating product development timelines. Established compatibility with a wide range of active pharmaceutical ingredients enhances their reliability across multiple therapeutic and nutraceutical applications. While vegetarian alternatives are gaining traction, their higher cost and technical limitations in stability and scalability continue to restrict widespread adoption. As a result, the combination of manufacturing efficiency, regulatory acceptance, and supply reliability positions gelatin soft capsules as the dominant segment in the UK market.

Based on Application:

• Pharmaceutical
• Nutraceutical
• Cosmeceutical

The nutraceutical segment dominates the United Kingdom Soft Gelatin Capsules Market, accounting for approximately 51% of total demand, primarily due to sustained consumer adoption of preventive health and daily supplementation practices. The UK government’s healthcare strategy increasingly emphasizes prevention and self-care, encouraging individuals to manage long-term health through nutrition and supplements. This has led to widespread consumption of products such as vitamin D and multivitamins, many of which are formulated in softgel form to improve absorption of lipid-based nutrients.

End-user consumption patterns further reinforce this dominance, as nutraceutical products are taken on a continuous, daily basis rather than for short-term treatment. This results in higher purchase frequency and consistent volume demand across retail pharmacies, supermarkets, and online platforms. Softgel capsules are particularly preferred for oil-based and fat-soluble ingredients due to their stability and ease of ingestion, making them the default delivery format for several high-demand supplement categories.

Additionally, the nutraceutical segment benefits from flexible product development and faster commercialization cycles compared to pharmaceuticals. Manufacturers can rapidly introduce targeted formulations addressing immunity, heart health, and cognitive wellness, aligning with evolving consumer preferences. The expansion of private-label offerings and direct-to-consumer supplement brands further supports high-volume distribution. This combination of continuous consumption, product versatility, and scalable production infrastructure firmly positions nutraceuticals as the leading application segment in the UK soft gelatin capsules market.

Gain a Competitive Edge with Our United Kingdom Soft Gelatin Capsules Market Report:

• United Kingdom Soft Gelatin Capsules Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• United Kingdom Soft Gelatin Capsules Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.